Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
J Cancer Res Clin Oncol ; 150(4): 174, 2024 Apr 03.
Article in English | MEDLINE | ID: mdl-38570343

ABSTRACT

PURPOSE: Endometrial cancer (EC) is the most common gynaecological cancer. Its incidence has been rising over the years with ageing and increased obesity of the high-income countries' populations. Metabolic syndrome (MetS) has been suggested to be associated with EC. The aim of this study was to assess whether MetS has a significant impact on oncological outcome in patients with EC. METHODS: This retrospective study included patients treated for EC between January 2010 and December 2020 in two referral oncological centers. Obesity, arterial hypertension (AH) and diabetes mellitus (DM) were criteria for the definition of MetS. The impact of MetS on progression free survival (PFS) and overall survival (OS) was assessed with log-rank test and Cox regression analyses. RESULTS: Among the 415 patients with a median age of 64, 38 (9.2%) fulfilled the criteria for MetS. The median follow-up time was 43 months. Patients suffering from MetS did not show any significant differences regarding PFS (36.0 vs. 40.0 months, HR: 1.49, 95% CI 0.79-2.80 P = 0.210) and OS (38.0 vs. 43.0 months, HR: 1.66, 95% CI 0.97-2.87, P = 0.063) compared to patients without MetS. Patients with obesity alone had a significantly shorter median PFS compared to patients without obesity (34.5 vs. 44.0 months, P = 0.029). AH and DM separately had no significant impact on PFS or OS (p > 0.05). CONCLUSION: In our analysis, MetS in patients with EC was not associated with impaired oncological outcome. However, our findings show that obesity itself is an important comorbidity associated with significantly reduced PFS.


Subject(s)
Endometrial Neoplasms , Metabolic Syndrome , Female , Humans , Metabolic Syndrome/complications , Metabolic Syndrome/epidemiology , Retrospective Studies , Prognosis , Obesity/complications , Endometrial Neoplasms/complications , Endometrial Neoplasms/therapy
2.
Asian J Surg ; 40(2): 106-115, 2017 Apr.
Article in English | MEDLINE | ID: mdl-26337376

ABSTRACT

BACKGROUND/OBJECTIVE: Currently, due to lack of optimal donors, more marginal organs are transplanted. Therefore, there is a high interest to ameliorate preischemic organ preservation, especially for critical donor organs. In this regard, a new histidine-tryptophane ketoglutarate (HTK-N) solution has been designed and its protective efficacy was compared with the standard preservation solutions-University of Wisconsin solution and standard HTK or Custodiol (Bretschneider's solution). METHODS: Seventy-two landrace pigs were included into the study, as donors and recipients. The donor kidneys were perfused during explantation with cold University of Wisconsin solution (n = 12), standard HTK (n = 12), or HTK-N solutions (n = 12), kept in the respective preservation solution at 4°C for 30 hours, implanted in the recipient pigs, and reperfused. The pigs survived in daily control for 7 days. The serum creatinine and blood urea nitrogen were assessed in pre- and postreperfusion phase on the 3rd day and 7th day posttransplantation. Additionally, tissue samples were taken to analyze the histopathological degree of tubular injury and regeneration before and after reperfusion. RESULTS: The three preservation groups were comparable in age, body weight, and hemodynamic parameters. According to statistical proof, they differed in none of the control parameters. CONCLUSION: Although the new preservation HTK solution is in several points a well-thought-out modification of the standard HTK solution, its preservation efficacy, at least for kidney preservation in a pig model for 30 hours, seems to be comparable to the current used solutions. A real advantage, however, could be confirmed in clinical settings, where marginal organs may influence the clinical outcome.


Subject(s)
Kidney Transplantation/methods , Organ Preservation Solutions/chemistry , Organ Preservation/methods , Adenosine/pharmacology , Allopurinol/pharmacology , Animals , Biopsy, Needle , Disease Models, Animal , Female , Glucose/pharmacology , Glutathione/pharmacology , Graft Rejection , Graft Survival , Immunohistochemistry , Insulin/pharmacology , Kidney Transplantation/adverse effects , Male , Mannitol/pharmacology , Organ Preservation Solutions/pharmacology , Potassium Chloride/pharmacology , Procaine/pharmacology , Raffinose/pharmacology , Random Allocation , Sensitivity and Specificity , Survival Rate , Swine , Treatment Outcome
3.
Asian J Surg ; 39(2): 66-73, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26216260

ABSTRACT

INTRODUCTION: One of the great challenges in pancreas transplantation is the ischemia reperfusion injury. It is mentioned that free oxygen and/or nitrogen radicals play a prominent role in this phase. To minimize this problem, a modified histidine-tryptophan-ketoglutarate (HTK) solution that contains modified antioxidants has been developed. Our aim was to evaluate this solution in improving the viability of the pancreas in comparison with standard HTK and University of Wisconsin (UW) solutions in a porcine model of pancreas transplantation. MATERIALS AND METHODS: Twenty-three Landrace pigs were divided into three identical groups. After a 10-hour preservation time at 4°C, the pancreas was implanted in the organs of the recipients in a standardized manner. Serum parameters were assessed prior to and after implantation on the 1(st) postoperative day, 3(rd) postoperative day, and 7(th) postoperative day. Furthermore, three biopsies were taken: prior to and after reperfusion, and on Day 7 to assess the grafts. RESULTS: An analysis of serum glucose among the three groups showed no significant differences. Evaluation of the insulin levels showed no significant difference between the modified and standard HTK groups; however, differences between HTK and UW were significant (p = 0.004 in favor of UW solutions). The histopathological results showed a trend of a higher grade of rejection of pancreas tissue in the UW group compared to both HTK groups. CONCLUSION: The modified HTK solution could preserve the pancreas for the preservation of the graft with similar results to those observed for standard solutions without any significant difference. The trend showed that the pathological finding in the UW group was not as good as that in the modified HTK and standard HTK groups.


Subject(s)
Organ Preservation Solutions , Pancreas Transplantation/methods , Adenosine , Allopurinol , Animals , Glucose , Glutathione , Insulin , Mannitol , Potassium Chloride , Procaine , Raffinose , Swine
4.
Int J Surg ; 18: 88-94, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25865085

ABSTRACT

INTRODUCTION: Acute rejection following kidney transplantation (KTx) is still one of the challenging complications leading to chronic allograft failure. The aim of this study was to investigate the role of microdialysis (MD) in the early detection of acute graft rejection factor following KTx in porcine model. METHODS: Sixteen pigs were randomized after KTx into case (n = 8, without immunosuppressant) and control groups (n = 8, with immunosuppressant). The rejection diagnosis in our groups was confirmed by histopathological evidences as "acute borderline rejection". Using MD, we monitored the interstitial concentrations of glucose, lactate, pyruvate, glutamate and glycerol in the transplanted grafts after reperfusion. RESULTS: In the early post-reperfusion phase the lactate level in our case group was significantly higher comparing to the control group and remained in higher levels until the end of monitoring. The lactate to pyruvate ratio showed a considerable increase in the case group during the post-reperfusion phase. The other metabolites (glucose, glycerol, glutamate) were nearly at the same levels at the end of our monitoring in both study groups. CONCLUSION: The increase in lactate and lactate to pyruvate ratios seems to be an indicator for early detection of acute rejection after KTx. Therefore, MD as a minimally invasive measurement tool may help to identify the need to immunosuppression adjustment in the early KTx phase before the clinical manifestation of the rejection.


Subject(s)
Graft Rejection/diagnosis , Kidney Transplantation , Microdialysis/methods , Acute Disease , Animals , Biomarkers/metabolism , Disease Models, Animal , Early Diagnosis , Glucose/metabolism , Glycerol/metabolism , Immunosuppression Therapy/methods , Immunosuppressive Agents/therapeutic use , Lactic Acid/metabolism , Monitoring, Physiologic/methods , Pyruvic Acid/metabolism , Sus scrofa
5.
Langenbecks Arch Surg ; 398(1): 87-97, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23070477

ABSTRACT

PURPOSE: During kidney transplantation (KTx), the length of cold ischemia time (CIT) and the subsequent changes in energy metabolism may lead to variations in interstitial metabolites. Using microdialysis (MD), we evaluated the effects of a short and long CIT on changes of these metabolites. METHODS: Sixteen pigs were randomized in two identical groups, one with a short CIT and the other one with a long CIT. Using MD in the transplanted grafts, we evaluated the parenchyma concentrations of glucose, lactate, pyruvate, glutamate and glycerol in different stages. RESULTS: We noted that during the warm ischemia time (WIT) and in the early post-reperfusion phase glucose levels increased more significantly in the long CIT group and remained high until the end of monitoring. At the end of CIT and during WIT, the long CIT group had a significantly higher glycerol level, but the level dropped gradually in the late post-reperfusion phase and reached a steady state in both groups. CONCLUSIONS: The extended CIT clearly results in considerably impaired graft metabolism. The high interstitial glucose levels within hours after KTx could be considered as a marker of primary delayed function of the graft. Furthermore, the glycerol value could reflect the extent of graft injury during the ischemia time or in case of acute impairment of graft perfusion.


Subject(s)
Cold Ischemia , Energy Metabolism/physiology , Kidney Transplantation/methods , Kidney/blood supply , Kidney/physiopathology , Microdialysis/methods , Animals , Blood Glucose/metabolism , Glutamic Acid/metabolism , Glycerol/metabolism , Graft Survival/physiology , Lactic Acid/metabolism , Pyruvic Acid/metabolism , Swine , Warm Ischemia
6.
J Obstet Gynaecol Can ; 34(4): 363-366, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22472337

ABSTRACT

BACKGROUND: Advances in surgical techniques and immunosuppressive therapy have improved graft survival in transplant recipients. However, intense long-term immunosuppression increases the incidence of cancer in these patients compared with the general population, not least because of viral infections. Cervical cancer is the third most common malignancy worldwide. In early invasive cervical cancer, surgery is the treatment of choice. CASE: In 2010, we performed a laparoscopically assisted vaginal hysterectomy (LAVH) in a 42-year-old patient with micro-invasive cervical adenocarcinoma (FIGO stage IA1) who had undergone two liver transplantations in 2006 and 2008. The patient was followed up for 18 months after surgery. Despite upper abdominal adhesions and minor difficulties in inserting the Veress needle, the pneumoperitoneum was created safely. The procedure was completed within 157 minutes without any intraoperative complications. Blood loss was less than 100 mL. Postoperative course was uncomplicated with minimal fluctuations in liver function markers. Immunosuppressive therapy was continued without modification. The patient was discharged on postoperative day 9. No complications or recurrence were reported during the 18-month follow-up. CONCLUSIONS: The laparoscopic approach is a justifiable form of surgical management in the treatment of a liver transplant recipient with early-stage cervical cancer.


Subject(s)
Hysterectomy/methods , Laparoscopy/methods , Liver Transplantation , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/surgery , Adult , Female , Humans , Liver Transplantation/adverse effects , Neoplasm Invasiveness , Reoperation , Risk Factors , Treatment Outcome , Uterine Cervical Neoplasms/etiology
7.
Langenbecks Arch Surg ; 397(5): 697-710, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21533917

ABSTRACT

BACKGROUND AND INTRODUCTION: Without adequate prophylaxis, liver transplantation (LTx) is frequently followed by hepatitis B virus (HBV) reinfection, which results in rapidly progressing liver disease and significantly decreased overall survival. In the last two decades, significant progress has been made in the prophylaxis and treatment of HBV. DISCUSSION: We present an overview of different protocols and regimens used for prophylaxis of HBV reinfection after LTx and describe the protocol implemented at our center. Following LTx, HBV reinfection can be effectively prevented by administration of anti-hepatitis B immunoglobulin (HBIg) alone or more recently in combination with antiviral nucleoside/nucleotide analogs (NUCs). Several studies reported good results with the use of HBIg alone, but combination treatment with HBIg and NUCs has proven to be a superior prophylactic regimen for HBV recurrence. At present, combination therapy (HBIg and a nucleoside or nucleotide analog) is the gold standard used in many transplantation centers. This preventive regimen reduces the risk of a recurrence of HBV infection and thereby the need for re-transplantation. Future and ongoing studies will show how long HBIg must be given after transplantation, especially when used in combination with potent antivirals, such as entecavir or tenofovir.


Subject(s)
Antiviral Agents/administration & dosage , Graft Rejection/prevention & control , Hepatitis B, Chronic/surgery , Immunoglobulins/administration & dosage , Liver Transplantation/methods , Combined Modality Therapy , Female , Graft Survival , Hepatitis B virus/drug effects , Hepatitis B, Chronic/diagnosis , Humans , Immunization, Passive , Lamivudine/administration & dosage , Liver Failure/diagnosis , Liver Failure/surgery , Liver Transplantation/adverse effects , Liver Transplantation/immunology , Male , Postoperative Care , Prognosis , Risk Assessment , Secondary Prevention , Survival Analysis , Treatment Outcome
8.
Surg Innov ; 18(4): 329-37, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21307018

ABSTRACT

AIMS: Different surgical transection methods have been used for distal pancreatectomy (DP), but none of them has yet achieved perfect results. This study compares 2 standard transection techniques with the alternative LigaSure technique. METHODS: Forty-eight pigs underwent a DP. Sixteen animals were operated on with a scalpel followed by hand suturing. Sixteen pigs received a DP using an Endo GIA, and the pancreas of 16 pigs was transected with LigaSure. The transection surface of remnant pancreas was observed for liquid collection and abscess on postoperative day 7. RESULTS: Operating time on the day of DP was significantly different, with a shorter operating time in the stapler and LigaSure groups. The morbidity on postoperative day 7 was similar in all groups. CONCLUSION: In the present experimental animal study, LigaSure seems to be fast and safe as well as comparable with the standard transection and closure techniques in DP.


Subject(s)
Pancreatectomy/methods , Suture Techniques , Abscess/etiology , Abscess/prevention & control , Animals , Drug Combinations , Fibrinogen/therapeutic use , Hemostasis, Surgical/methods , Hemostatics/therapeutic use , Pancreatectomy/adverse effects , Swine , Thrombin/therapeutic use
9.
Surg Innov ; 18(4): 321-8, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22308094

ABSTRACT

BACKGROUND: Microdialysis (MD) can detect organ-related metabolic changes before they become measurable in plasma through the biochemical parameters. This study aims to evaluate the early detection of metabolic changes during experimental kidney transplantation (KTx). MATERIAL AND METHODS: During preparation of 8 donor kidneys, one MD catheter was inserted in the renal cortex and samples were collected. After a 6-hour cold ischemia time (CIT), kidneys were implanted in the 8 recipient pigs. Throughout the warm ischemia time (WIT) and after reperfusion, kidneys were monitored. The interstitial glucose, lactate, pyruvate, glutamate, and glycerol concentrations were evaluated. RESULTS: A significant decline in glucose level was observed at the end of CIT. The lactate level was reduced to the minimum point of 0.35 ± 0.08 mmol/L in CIT. After reperfusion, lactate values raised significantly. During the WIT, the pyruvate level increased, continued until the end of the WIT. For glutamate, a steady increase was noted during explantation, CIT, WIT, and early reperfusion phases. The increase of glycerol value continued in the early postreperfusion, which was then followed by a sharp decline. CONCLUSION: MD is a fast and simple minimally invasive method for measurement of metabolic substrates in renal parenchyma during KTx. MD offers the option of detecting minor changes of interstitial glucose, lactate, pyruvate, glutamate, and glycerol in every stage of KTx. Through the use of MD, metabolic changes can be continuously monitored during the entire procedure of KTx.


Subject(s)
Graft Survival/physiology , Kidney Transplantation/adverse effects , Kidney/metabolism , Microdialysis , Monitoring, Intraoperative/methods , Animals , Cold Ischemia , Early Diagnosis , Glucose/metabolism , Glutamic Acid/metabolism , Glycerol/metabolism , Lactic Acid/metabolism , Models, Animal , Pyruvic Acid/metabolism , Reproducibility of Results , Swine
10.
Liver Transpl ; 14(11): 1637-47, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18975272

ABSTRACT

Although the use of non-heart-beating donors (NHBD) is the oldest type of organ transplantation, the results were and still are disappointing. To consider using a liver from NHBD, it is of importance to assess the graft viability. Our aim was to assess the role of reduced liver glutathione (rGSHL) as a potential predictive marker of liver function before transplantation. Autotransplanted livers were subjected to 0, 60, and 90 minutes of ischemia in 20 pigs. We analyzed systemic cardiocirculatory parameters, bowel ischemia by endotoxin, endotoxin-neutralizing capacity, oxidative stress, hepatic perfusion parameters, liver enzymes, local bowel ischemia, and liver oxidative stress (rGSHL and oxidized glutathione in the liver). Autotransplantation was comparable to donor explantation/recipient transplantation with respect to systemic and hepatic parameters. Liver ischemia for 0, 60, and 90 minutes resulted in survival in 100% (NHBD-0), 71% (NHBD-60), and 57% (NHBD-90) of animals. Of all parameters, only hepatic microperfusion, pHi of the sigmoid colon, and bowel ischemia by endotoxin in the NHBD-90 group showed significant changes compared to NHBD-60 and control animals. Although systemic endotoxin-neutralizing capacity and total glutathione in erythrocytes levels were mainly influenced by cold perfusion, hepatic oxidative stress increased with ischemia time. The cut-off value of 11.5 ng/mmol of rGSHL could distinguish survivors from nonsurvivors, independent of the ischemia time. In conclusion, rGSHL has the potential of becoming an important viability marker, as it could predict survival in autotransplantation NHBD model regardless of the ischemia time. Further investigation to declare reasons for differing rGSHL levels within the liver is required.


Subject(s)
Glutathione/metabolism , Liver Transplantation/methods , Liver/metabolism , Animals , Biomarkers/metabolism , Cadaver , Endotoxins/metabolism , Erythrocytes/metabolism , Graft Survival , Humans , Ischemia , Liver/pathology , Liver Diseases/pathology , Liver Diseases/therapy , Oxidative Stress , Swine , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...